170 related articles for article (PubMed ID: 22638735)
1. Antitumor carboplatin is more toxic in tumor cells when photoactivated: enhanced DNA binding.
Mlcouskova J; Stepankova J; Brabec V
J Biol Inorg Chem; 2012 Aug; 17(6):891-8. PubMed ID: 22638735
[TBL] [Abstract][Full Text] [Related]
2. Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles.
Štarha P; Trávníček Z; Dvořák Z; Radošová-Muchová T; Prachařová J; Vančo J; Kašpárková J
PLoS One; 2015; 10(4):e0123595. PubMed ID: 25875850
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
4. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
[TBL] [Abstract][Full Text] [Related]
5. DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells.
Unger FT; Klasen HA; Tchartchian G; de Wilde RL; Witte I
BMC Cancer; 2009 Oct; 9():359. PubMed ID: 19818145
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
9. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
Westendorf AF; Bodtke A; Bednarski PJ
Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
[TBL] [Abstract][Full Text] [Related]
10. N,N-Dialkylbenzimidazol-2-ylidene platinum complexes - effects of alkyl residues and ancillary cis-ligands on anticancer activity.
Rehm T; Rothemund M; Bär A; Dietel T; Kempe R; Kostrhunova H; Brabec V; Kasparkova J; Schobert R
Dalton Trans; 2018 Dec; 47(48):17367-17381. PubMed ID: 30480671
[TBL] [Abstract][Full Text] [Related]
11. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
12. DN604: A platinum(II) drug candidate with classic SAR can induce apoptosis via suppressing CK2-mediated p-cdc25C subcellular localization in cancer cells.
Chen F; Jin X; Zhao J; Gou S
Exp Cell Res; 2018 Mar; 364(1):68-83. PubMed ID: 29397071
[TBL] [Abstract][Full Text] [Related]
13. Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells.
Pracharova J; Zerzankova L; Stepankova J; Novakova O; Farrer NJ; Sadler PJ; Brabec V; Kasparkova J
Chem Res Toxicol; 2012 May; 25(5):1099-111. PubMed ID: 22420335
[TBL] [Abstract][Full Text] [Related]
14. A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin.
Hongo A; Seki S; Akiyama K; Kudo T
Int J Biochem; 1994 Aug; 26(8):1009-16. PubMed ID: 8088411
[TBL] [Abstract][Full Text] [Related]
15. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry.
Hah SS; Stivers KM; de Vere White RW; Henderson PT
Chem Res Toxicol; 2006 May; 19(5):622-6. PubMed ID: 16696564
[TBL] [Abstract][Full Text] [Related]
17. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Mellish KJ; Kelland LR; Harrap KR
Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
[TBL] [Abstract][Full Text] [Related]
18. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin.
Hamelers IH; van Loenen E; Staffhorst RW; de Kruijff B; de Kroon AI
Mol Cancer Ther; 2006 Aug; 5(8):2007-12. PubMed ID: 16928821
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
Ferguson PJ; Currie C; Vincent MD
Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
